New immunosuppression strategies are needed to improve kidney allograft survival in blacks.
Tesi
R J
RJ
Department of Surgery, Tulane University School of Medicine, New Orleans, Louisiana 70112, USA.
Dagoglou
P
P
Zarifian
A
A
Etheredge
E E
EE
D000328:Adult; D001741:Black or African American; D044383:Black People; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005500:Follow-Up Studies; D006084:Graft Rejection / Q000453:epidemiology; D006085:Graft Survival; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D015999:Multivariate Analysis; D011241:Prednisone / Q000627:therapeutic use; D012189:Retrospective Studies; D018570:Risk Assessment; D013997:Time Factors; D014481:United States; D044465:White People
D007166:Immunosuppressive Agents; D016572:Cyclosporine; D011241:Prednisone; D008775:Methylprednisolone